Alger Associates, Inc. 13D and 13G filings for Nevro Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-09-10 4:00 pm Sale |
2024-08-31 | 13G | Nevro Corp. NVRO |
Alger Associates, Inc. | 67,827 0.200% |
-2,047,837![]() (-96.79%) |
Filing |
2024-02-14 4:13 pm Purchase |
2023-12-31 | 13G | Nevro Corp. NVRO |
Alger Associates, Inc. | 2,115,664 5.800% |
874,249![]() (+70.42%) |
Filing |
2021-09-10 4:11 pm Sale |
2021-08-31 | 13G | Nevro Corp. NVRO |
Alger Associates, Inc. | 1,241,415 3.560% |
-895,197![]() (-41.90%) |
Filing |
2021-02-16 4:54 pm Purchase |
2020-12-31 | 13G | Nevro Corp. NVRO |
Alger Associates, Inc. | 2,136,612 6.210% |
222,654![]() (+11.63%) |
Filing |